Skip to main content

Table 1 Clinical characteristics and outcome of the study population

From: Microbiological profile of patients treated for postoperative peritonitis: temporal trends 1999–2019

Variables

Overall

N = 422 patients

Missing

value

MDRO

group

N = 188 patients

MDRO-free group

N = 234 patients

p value

Demographic characteristics

Age—years, median [IQR]

61 [49–73]

0

64 [53–74]

59 [46–72]

0.0137

Patients aged ≥ 80 years—n (%)

45 (11)

0

24 (13)

21 (9)

0.208

Male sex—n (%)

221 (52)

0

115 (61)

106 (45)

0.0012

Medical history and underlying diseases

No underlying disease—n (%)

9 (2)

0

4 (2)

5 (2)

1.000

Rapidly fatal underlying disease (survival < 1 year)—n (%)

111 (26)

0

58 (31)

53 (23)

0.057

Charlson score, median [IQR]

4 [1–6]

0

4 [2–6]

3 [1–5]

0.027

 Diabetes mellitus*—n (%)

77 (18)

0

38 (20)

39 (17)

0.348

 Malignancy*—n (%)

165 (39)

0

82 (44)

83 (35)

0.088

 Chronic obstructive pulmonary disease*—n (%)

46 (11)

0

25 (13)

21 (9)

0.156

 Moderate to severe chronic kidney disease*—n (%)

17 (4)

0

7 (4)

10 (4)

0.809

Immunosuppression—n (%)

75 (18)

0

40 (21)

35 (15)

0.091

Initial surgery

Emergency surgery—n (%)

162 (38)

0

82 (44)

80 (34)

0.047

Contaminated or septic surgery—n (%)

159 (38)

0

79 (42)

80 (34)

0.098

Digestive surgery—n (%)

367 (87)

0

166 (88)

201 (86)

0.466

Bariatric surgery—n (%)

79 (19)

0

19 (24)

60 (76)

 < 0.0001

Gynaecological surgery—n (%)

24 (6)

0

6 (3)

18 (8)

0.056

Curative antibiotic therapy—n (%)

116 (27)

0

55 (29)

61 (26)

0.054

Abdominal reoperation before diagnosis of POP—n (%)

114 (27)

0

53 (28)

61 (26)

0.625

Delay between initial surgery and reoperation for POP, days, median [IQR]

7 [4–12]

1

8 [4–13]

7 [4–11.5]

0.214

Antimicrobial therapy before reoperation for POP—n (%)

278 (66)

1

130 (69)

148 (63)

0.203

Ongoing antimicrobial therapy at the time of diagnosis of POP—n (%)

232 (56)

4

111 (60)

121 (52)

0.099

Surgical management of POP

Colonic or rectal source of contamination—n (%)

119 (28)

0

71 (64)

48 (42)

0.0008

Small bowel source of contamination—n (%)

117 (28)

0

55 (56)

62 (53)

0.599

Gastroduodenal source of contamination—n (%)

99 (23)

0

28 (38)

71 (60)

0.004

Pancreas and biliary source of contamination—n (%)

23 (5)

0

13 (7)

10 (4)

0.281

Perforation—n (%)

124 (29)

0

57 (30)

67 (29)

0.705

Anastomosis dehiscence—n (%)

155 (37)

0

64 (34)

91 (39)

0.304

Abscess—n (%)

80 (19)

0

37 (20)

43 (18)

0.733

No cause—n (%)

67 (16)

0

26 (14)

41 (18)

0.302

Source control for POP

     

Resection/excision—n (%)

292 (69)

4

128 (68)

164 (70)

0.717

Ostomy—n (%)

242 (57)

4

115 (61)

127 (54)

0.136

Anastomosis—n (%)

37 (9)

4

12 (4)

25 (11)

0.165

Patch/suture—n (%)

109 (26)

4

40 (21)

69 (29)

0.055

Intraoperative drainage—n (%)

351 (82)

4

156 (83)

195 (83)

1.000

Severity criteria at the time of ICU admission for POP

SAPS II score, median [IQR]

47 [35–58]

1

50 [36–59]

45 [33–57.5]

0.059

SAPS II score ≥ 40—n (%)

281 (67)

1

110 (71)

171 (64)

0.160

SOFA score, median [IQR]

8 [5–10]

5

8 [5–10]

8 [4–10]

0.992

Respiratory failure—n (%)

184 (45)

16

79 (43)

105 (47)

0.485

Hemodynamic failure—n (%)

284 (70)

16

131 (72)

153 (68)

0.421

Renal failure—n (%)

109 (27)

17

42 (23)

67 (30)

0.115

Outcome

Reoperation—n (%)

203 (48)

0

89 (47)

114 (49)

0.778

Duration of ICU stay of survivors—days; median [IQR]

14 [8–25]

0

16 [9–28]

12 [7–25]

0.080

Duration of mechanical ventilation—days; median [IQR]

7 [3–15]

0

7 [4–16]

6 [3–15]

0.214

Death in ICU—n (%)

134 (32)

0

64 (34)

70 (30)

0.365

Delay of death in the ICU—days; median [IQR]

14 [3–26]

0

12 [3–27]

15 [3–25]

0.675

Death in hospital—n (%)

148 (35)

0

76 (40)

72 (31)

0.038

  1. *According to the Charlson’s comorbidity index